Inclusion completed

A phase 1, open label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function

Cancer type: Solide tumores

Phase: I

Principal Investigator: Sandstöm Per

Country: SE

Keywords: Sweden, panobinostat, solid tumors

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01007968?term=NCT01007968&rank=1